Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Medesis Pharma S.A. ALMDP Apr 25, 2025 0.35 0.00   
 Media 6 EDI Apr 25, 2025 10.70 0.00   
 Media Lab SpA MLLAB Apr 25, 2025 2.18 0.00   
 Median Technologies ALMDT Apr 25, 2025 2.56 -1.12   
 Medincell S.A. MEDCL Apr 25, 2025 14.97 +0.13   
 Memscap MEMS Apr 25, 2025 4.00 +1.52   
 Mercialys SA MERY Apr 25, 2025 11.52 -0.17   
 Mersen MRN Apr 25, 2025 18.58 +1.20   
 Metavisio S.A ALTHO Apr 25, 2025 0.03 -4.08   
 Methanor ALMET Apr 25, 2025 2.45 0.00   
 Metropole Television SA MMT Apr 25, 2025 14.00 +1.16   
 Mexedia S.P.A ALMEX Apr 25, 2025 1.30 +8.33   
 MG International ALMGI Apr 25, 2025 3.50 0.00   
 MGI Digital Graphic Technology ALMDG Apr 25, 2025 13.14 -0.76   
 Michelin ML Apr 25, 2025 31.38 +1.72   
 Miliboo ALMLB Apr 25, 2025 1.27 -2.29   
 MINT ALMIN Apr 25, 2025 4.65 +2.20   
 Mon Courtier Energie Groupe S.A. ALMCE Apr 25, 2025 4.44 +1.83   
 Moncey (Fin) Nom FMONC Apr 25, 2025 107.90 +1.31   
 MONTEA C.V.A. MONT Apr 25, 2025 62.50 +0.84   
 Montepino Logistica Socimi S.A. MLMTP Apr 25, 2025 10.10 0.00   
 Mota-Engil SGPS SA EGL Apr 25, 2025 3.53 +5.37   
 Moulinvest ALMOU Apr 25, 2025 15.70 +1.95   
 MR Bricolage SA ALMRB Apr 25, 2025 6.94 -0.86   
 Munic S.A. ALMUN Apr 25, 2025 0.53 +8.61   
 MyHotelMatch MHM Apr 25, 2025 0.48 -15.61   
 Nacon S.A. NACON Apr 25, 2025 0.48 0.00   
 Nam.R S.A. ALNMR Apr 25, 2025 0.28 -2.76   
 Nanobiotix NANO Apr 25, 2025 2.86 -1.55   
 Navigator Company SA NVG Apr 25, 2025 3.32 +0.42   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.